Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Very early researchStudy completedNCT02115828
What this trial is testing

Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableUnknownNCT03934164
What this trial is testing

Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 600
Testing effectiveness (Phase 2)UnknownNCT05458544
What this trial is testing

[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
FutureChem 26
Testing effectiveness (Phase 2)Looking for participantsNCT05762536
What this trial is testing

Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Erasmus Medical Center 245
Testing effectiveness (Phase 2)UnknownNCT04586543
What this trial is testing

Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

Who this might be right for
Metastatic Castration-resistant Prostate CancerAdenocarcinoma of the Prostate
László Mangel 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT02452008
What this trial is testing

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Not applicableStudy completedNCT01621425
What this trial is testing

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Who this might be right for
Breast CancerMetastatic Castration-resistant Prostate Carcinoma
Radboud University Medical Center 25
Large-scale testing (Phase 3)Looking for participantsNCT06470243
What this trial is testing

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
SWOG Cancer Research Network 528
Very early researchStudy completedNCT02204943
What this trial is testing

Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Bone Metastatic Castration-Resistant Prostate Cancer
Duke University 20
Testing effectiveness (Phase 2)WithdrawnNCT03709550
What this trial is testing

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma in the Soft Tissue+6 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02124668
What this trial is testing

Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Castration-Resistant Prostate CancerProstate Cancer
Astellas Pharma Europe B.V. 30
Testing effectiveness (Phase 2)Ended earlyNCT04556617
What this trial is testing

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Opna Bio LLC 19
Testing effectiveness (Phase 2)Looking for participantsNCT06615752
What this trial is testing

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Charles Drew University of Medicine and Science 99
Early research (Phase 1)Active Not RecruitingNCT03582475
What this trial is testing

Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Bladder Urothelial Carcinoma+14 more
Jonsson Comprehensive Cancer Center 15
Large-scale testing (Phase 3)Ended earlyNCT03850795
What this trial is testing

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Hinova Pharmaceuticals USA, Inc. 104
Early research (Phase 1)Study completedNCT03774056
What this trial is testing

A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 43
Testing effectiveness (Phase 2)Study completedNCT02325557
What this trial is testing

ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
CancerProstate Cancer
Advaxis, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07745361
What this trial is testing

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Castration-Resistant Prostate CancerProstate Cancer+1 more
Monte Rosa Therapeutics, Inc 25
Early research (Phase 1)Study completedNCT01634061
What this trial is testing

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 43
Next Page